Hansjorg Wyss
Direktor/Vorstandsmitglied bei Avery Therapeutics, Inc.
Aktive Positionen von Hansjorg Wyss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Avery Therapeutics, Inc.
Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Hansjorg Wyss
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Avery Therapeutics, Inc.
Avery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avery Therapeutics, Inc. engages in the development of tissue-engineered therapeutics to treat diseases and injuries to human muscle. Its product MyCardia™ is a tissue-engineered heart graft developed to treat heart failure. The company was founded by Steve Goldman and Jordan Lancaster in 2013 and is headquartered in Tucson, AZ. | Commercial Services |
- Börse
- Insiders
- Hansjorg Wyss
- Erfahrung